Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874396 | PMC |
| http://dx.doi.org/10.1186/s12885-025-13821-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.
Front Immunol
February 2025
Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFCorrection: CAR-NK cells with dual targeting of PD-L1 and MICA/B in lung cancer tumor models.
BMC Cancer
March 2025
Henan Province Engineering Research Center of Innovation for Synthetic Biology, School of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan, China.
Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.
Nat Med
March 2024
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies.
Pharmaceutics
April 2022
The Molecular Genetics Thalassemia Department, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
Advanced therapy medicinal products (ATMPs) are medicines for human use based on genes, cells or tissue engineering. After clear successes in adults, the nascent technology now sees increasing pediatric application. For many still untreatable disorders with pre- or perinatal onset, timely intervention is simply indispensable; thus, prenatal and pediatric applications of ATMPs hold great promise for curative treatments.
View Article and Find Full Text PDFNK cell surveillance of hematological malignancies. Therapeutic implications and regulation by chemokine receptors.
Mol Aspects Med
August 2021
Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Pasteur Institute Italia-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161, Rome, Italy. Electronic address:
NK cells are circulating innate lymphoid cells that constantly move from bloodstream into tissues, exerting several functions including tumor surveillance. For this reason, NK cells are considered attractive target for cancer immunotherapy. Several strategies are employed to harness NK cell efficacy especially in hematological tumors, including adoptive transfer, genetic manipulation to overexpress chimeric antigen receptors and cytokine or immunomodulatory drug treatments of ex-vivo cultivated and expanded NK cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!